Cytotheryx, Inc.

Cytotheryx, Inc.

Private
Rochester, MinnesotaHealthcare & Life Scienceshttps://cytotheryx.com

Last Round

Series A

Jan 12, 2026

Total Funding Raised

$1.31M

Company Overview

Cytotheryx, Inc. is a biotechnology company developing cell-based treatments for acute, chronic, and rare liver diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

primary human hepatocytescell therapyliver cell supplycell manufacturingxenotransplantation platformliver cell therapydrug toxicity testingregenerative medicinedrug discoverybio-incubator platformpreclinical researchbioartificial livercryopreserved hepatocytesporcine hepatocytes

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cytotheryx, Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cytotheryx, Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AJan 12, 2026
DebtAug 28, 2024
GrantAug 1, 2024
GrantOct 24, 2023
DebtOct 19, 2020

Cytotheryx, Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 6, 2026

    Purchased a 60-year-old building at 2112 15th St. NW.

  • Mar 1, 2026

    Acquired two Rochester facilities for $7.6 million.

Cytotheryx, Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cytotheryx, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cytotheryx, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersRochester, Minnesota
Employee Range16
Year Founded2019
Last FundingJan 12, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.